Bio-Techne

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals.[1]

For other uses, see Techne (disambiguation).
Bio-Techne Corporation
TypePublic company
IndustryBiotechnology
Founded1976 (1976)
FounderDr. Roger C. Lucas
HeadquartersMinneapolis, Minnesota, U.S.
Key people
Chuck Kummeth, President & CEO
James Hippel, CFO
Robert V. Baumgartner, Chairman
ProductsProteins
Reagents
Diagnostic instruments
RevenueIncrease US$1.120 billion (2022)
Increase US$229 million (2020)
Total assetsIncrease US$2.027 billion (2020)
Total equityIncrease US$1.381 billion (2020)
Number of employees
2,300 (2020)
Websitebio-techne.com
Footnotes / references
[1]

History

The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company.[1]

In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company.[2]

In July 2013, the company acquired Bionostics for $104 million.[3][4]

In February 2014, the company changed its name to Bio-Techne.[5]

In April 2014, the company agreed to acquire Shanghai PrimeGene Bio-Tech Company (PrimeGene).[6][7]

In July 2014, the company acquired Novus Biologicals for $60 million.[8][9][10]

In August 2014, the company acquired ProteinSimple for $300 million.[11]

In November 2014, the company agreed to acquire CyVek for $60 million plus up to an additional $135 million in earn-out payments.[12][13][14]

In June 2015, the company agreed to acquire Cliniqa Corporation.[15][16]

In March 2016, the company acquired Zephyrus Biosciences.[17][18][19]

In July 2016, the company acquired Space Import-Export.[20]

In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments.[21][22][23]

In September 2017, the company acquired Trevigen.[24][25]

In January 2018, the company acquired Atlanta Biologicals.[26][27]

In June 2018, the company agreed to acquire Quad Technologies.[28][29]

In August 2018, the company acquired Exosome Diagnostics for $250 million plus up to an additional $325 million in milestone payments.[30]

In June 2019, the company acquired B-Mogen.[31][32]

In April 2021, the company acquired Asuragen for $215 million plus up to an additional $105 million in milestone payments.[33]

In June 2022, the business announced it would acquire Namocell Inc.[34]

In June 2023, Bio-Techne announced it would acquire Lunaphore Technologies SA,[35] the transaction was completed the following month[36]

References
  1. "Bio-Techne Corporation 2020 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
  2. "Board Of Directors Appoints Charles Kummeth As Chief Executive Officer And Director Of Techne Corporation" (Press release). PR Newswire. March 18, 2013.
  3. Resende, Patricia (July 23, 2013). "Techne Corp. completes $104M cash purchase of Bionostics, names new CTO". American City Business Journals.
  4. "Local company news". Star Tribune. July 22, 2013.
  5. "Techne Corporation Announces New Trade Name, Bio-Techne". PR Newswire. February 10, 2014.
  6. "Bio-Techne Announces Acquisition Agreement". PR Newswire. April 15, 2014.
  7. Hammerand, Jim (April 15, 2014). "Techne has deal to buy Chinese genetics firm". American City Business Journals.
  8. "Bio-Techne Acquires Novus Biologicals for $60M". genengnews.com. July 3, 2014.
  9. "Bio-Techne Announces Agreement to Acquire Novus Biologicals for $60M". The Wall Street Journal. July 3, 2014.
  10. "Bio-Techne Announces Agreement To Acquire Novus Biologicals". PR Newswire. July 2, 2014.
  11. "Bio-Techne Announces ProteinSimple Acquisition Completion" (Press release). PR Newswire. August 1, 2014.
  12. "Bio-Techne Announces Agreement To Acquire CyVek" (Press release). PR Newswire. November 4, 2014.
  13. "Bio-Techne to Acquire CyVek for Up to $195M+". genengnews.com. November 5, 2014.
  14. "Wallingford's CyVek acquired by Minnesota company". New Haven Register. November 13, 2014.
  15. "Bio-Techne Corporation Agrees to Acquire Cliniqa Corporation" (Press release). PR Newswire. June 5, 2015.
  16. "Cliniqa Now Owned by Bio-Techne". genengnews.com. June 5, 2015.
  17. "Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc" (Press release). PR Newswire. March 21, 2016.
  18. "Bio-Techne Acquires Zephyrus Biosciences". genengnews.com. March 21, 2016.
  19. "Bio-Techne Acquires Zephyrus Biosciences". The Wall Street Journal. March 22, 2016.
  20. "Bio-Techne Acquires Space Import-Export And Strengthens European Leadership Team" (Press release). PR Newswire. July 1, 2016.
  21. "Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics" (Press release). PR Newswire. August 1, 2016.
  22. "Bio-Techne to Acquire Advanced Cell Diagnostics for Up to $325M". genengnews.com. July 7, 2016.
  23. Al Idrus, Amirah (July 7, 2016). "MedTech Bio-Techne shells out $250M for Advanced Cell Diagnostics". FierceBiotech.
  24. "Bio-Techne Acquires Trevigen Inc" (Press release). PR Newswire. September 5, 2017.
  25. Bakolia, Ravikash (September 5, 2017). "Bio-Techne acquires privately held Trevigen". S&P Global.
  26. "Bio-Techne Acquires Atlanta Biologicals Inc" (Press release). PR Newswire. January 2, 2018.
  27. Carlson, Joe (January 2, 2018). "Bio-Techne buys Atlanta Biologicals in cash deal". Associated Press.
  28. "Bio-Techne To Acquire Quad Technologies" (Press release). PR Newswire. June 7, 2018.
  29. Bakolia, Ravikash (June 7, 2018). "Bio-Techne to acquire privately held Quad Technologies". S&P Global.
  30. "Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc" (Press release). PR Newswire. August 1, 2018.
  31. "Bio-Techne To Acquire B-MoGen Biotechnologies Inc" (Press release). PR Newswire. June 4, 2019.
  32. Wittenberg, Alex (June 5, 2019). "Bio-Techne acquires Minneapolis gene-editing firm formed at U of M". American City Business Journals.
  33. "Bio-Techne Completes Acquisition of Asuragen, Inc" (Press release). PR Newswire. April 6, 2021.
  34. "Bio-Techne to Acquire Namocell".
  35. https://investors.bio-techne.com/press-releases/detail/373/bio-techne-to-acquire-lunaphore
  36. https://www.biospace.com/article/releases/bio-techne-completes-lunaphore-acquisition/?s=79
  • Official website
  • Business data for Bio-Techne Corporation:
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.